肝硬化患者肝相关死亡率男女相似
该研究基于芝加哥电子健康记录数据库链接器官共享网络和死亡登记数据,分析20045例肝硬化患者,发现女性全因死亡风险较低(调整HR 0.85),但肝相关死亡风险与男性相似(亚分布HR 0.93),尽管女性 listing 和移植率更低。
要点
- 女性肝硬化患者全因死亡风险低于男性(调整HR 0.85)。
- 女性肝相关死亡风险与男性相似(亚分布HR 0.93)。
- 女性 listing 和移植率低于男性,但未增加肝相关死亡风险。
核心结论
- 女性肝硬化患者全因死亡风险较低,可能由非肝相关死亡减少驱动。
- 女性肝相关死亡风险与男性相似,尽管 listing 和移植率更低。
研究设计与样本
- 回顾性队列研究,纳入20045例肝硬化患者,使用芝加哥电子健康记录数据库链接器官共享网络和州死亡登记数据。
- 采用调整Cox生存分析和竞争风险分析,计算肝相关死亡的亚分布风险比。
主要发现
- 女性胆汁淤积性肝病比例高于男性(17.1% vs 6.2%,p<0.001)。
- 女性非酒精性脂肪性肝炎比例高于男性(29.8% vs 21.2%,p<0.001)。
- 女性门脉高压并发症较少,随访期间峰值MELD-Na评分较低。
- 女性全因死亡调整HR为0.85(95%CI 0.80-0.90)。
- 女性肝相关死亡亚分布HR为0.93(95%CI 0.87-1.00)。
关键数值与推荐
- 女性 listing 率7.5% vs 男性9.8%(p<0.001)。
- 女性移植率3.5% vs 男性5.2%(p<0.001)。
- 曾列入等待名单的女性全因死亡亚分布HR 1.09(95%CI 0.88-1.35),肝相关死亡亚分布HR 1.12(95%CI 0.87-1.43)。
临床怎么用
- 临床中应认识到女性肝硬化患者全因死亡风险较低,但肝相关死亡风险与男性相当。
- 女性 listing 和移植率较低,需关注是否存在性别差异并优化评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Sex-based differences are known to significantly contribute to outcomes in patients with chronic liver diseases; however, the role of patient sex in cirrhosis is unclear. We aimed to study the relationship between patient sex and cirrhosis. METHODS: We analyzed a cohort of 20,045 patients with cirrhosis using a Chicago-wide electronic health record database that was linked with the United Network for Organ Sharing and cause of death data from the state death registry. Adjusted Cox survival analyses and competing risk analyses were performed to obtain subdistribution hazard ratios (HRs) for liver-related cause of death. RESULTS: Female and male patients had similar age, racial distribution, insurance status, and comorbidity status by Elixhauser score. Females had higher rates of cholestatic liver disease (17.1% vs. 6.2%, p <0.001) and non-alcoholic steatohepatitis (29.8% vs. 21.2%, p <0.001) than males. They were less likely to have portal hypertensive complications and had lower peak MELD-Na scores during follow-up. Female sex was associated with a decreased hazard of all-cause mortality (adjusted HR 0.85; 95% CI 0.80-0.90). This effect was attenuated when liver-related mortality was examined (subdistribution HR 0.93; 95% CI 0.87-1.00). No significant difference was noted for women who were 'ever-listed' in competing risk analyses for either all-cause mortality (subdistribution HR 1.09; 95% CI 0.88-1.35) or liver-related death (subdistribution HR 1.12; 95% CI 0.87-1.43), despite lower rates of listing (7.5% vs. 9.8%; p <0.001) and transplant (3.5% vs. 5.2%; p <0.001). CONCLUSIONS: In this longitudinal study of patients with cirrhosis, female sex was associated with a survival advantage likely driven by lower rates of non-liver-related death. Women were not at an increased risk of liver-related death despite lower rates of listing and transplantation. LAY SUMMARY: Patient sex is an important contributor in many chronic diseases, including cirrhosis. Prior studies have suggested that female sex is associated with worse outcomes. We analyzed a cohort of 20,045 patients with cirrhosis using a Chicago-wide electronic health record database. Using multivariate competing risk analyses, we found that female sex in cirrhosis is actually associated with a lower risk of all-cause mortality and has no association with liver-related mortality. Our findings are novel because we show that women with cirrhosis have a similar risk of liver-related death as their male counterparts, despite lower rates of listing and transplantation.
引用
- Mazumder NR, Celaj S, Atiemo K, et al. Liver-related mortality is similar among men and women with cirrhosis. J Hepatol. 2020. PMID: 32344052. doi:10.1016/j.jhep.2020.04.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。